Regulus Inks microRNA Drugs Collaboration with AstraZeneca
August 16, 2012
Regulus Inks microRNA Drugs Collaboration with AstraZeneca
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- With Three Years of Cash in the Bank, Regulus Aims for Two INDs by 2014
November 29, 2012 / Gene Silencing News - Mirna Closes $34.5M Series C Round as microRNA Drugs Gain Investor Interest
October 25, 2012 / Gene Silencing News - Cenix to Provide Research Services to Debiopharm
May 23, 2013 / Gene Silencing News - Santaris, Miragen Expand microRNA Partnership to Include Additional Targets
January 10, 2013 / Gene Silencing News - In 2012, Top microRNA Drug Developers Pull in Nearly $150M in Funding
December 20, 2012 / Gene Silencing News